Chaves LA , Gadsby DC .

R01 DK051767 NIDDK NIH HHS , DK51767 NIDDK NIH HHS

	Figure 1. Structural comparison of heterodimeric, TM287/288 (A–C), and homodimeric, Sav1866 (D–F), ABC transporters. (A and D) Cartoon (left) and surface (right) representations of TM287/288 (A; PDB accession no. 3QF4) and Sav1866 (D; PDB accession no. 2ONJ) viewed along expected membrane plane (boundaries indicated by gray lines). Transmembrane domains equivalent to CFTR’s transmembrane domain 1 and transmembrane domain 2 are forest green and blue, respectively; NBDs equivalent to CFTR’s NBD1 and NBD2 are lime and cyan, respectively. Walker A motifs are shown in red, Walker B in orange, ABC signature in purple, bound AMPPNP as yellow spheres, and target residue positions as CPK spheres. (B and E) Magnified (∼2×) surface views of the boxed cytoplasmic regions in A and D. Interfacial residues equivalent to CFTR’s ABC signature-sequence targets S549 and S1347 are exposed in TM287/288 (B) but buried in Sav1866 (E). (C and F) NBD dimer interfaces viewed from the membrane, after 90° rotation from B and E views and removal of transmembrane domains, with solid (left) and transparent (right) surfaces. In Sav1866 (F), a signature sequence and AMPPNP are buried in the tight NBD dimer interface in each composite site, whereas in TM287/288 (C), both signature sequences are exposed and a single AMPPNP is bound by the CFTR equivalent NBD1 Walker A motif.
	Figure 2. Size comparison of MTS reagents, nucleotides, NEM, and MTS-biotin–avidin complex, shown as CPK-colored spheres, except for AMPPNP (yellow spheres; from TM287/288 structure; PDB accession no. 3QF4) and avidin tetramer (orange ribbon). MTSET+, MTSACE, and MTSES− all approximate cylinders ∼12 × ∼6-à diameter, and NEM is ∼8 × ∼6-à diameter. Minimum box sizes to fit low energy rotamers are shown: MTS-glucose, ∼16 × ∼8 × ∼7 à ; MTS-biotin, ∼19 × ∼7 × ∼6 à ; MTS-rhodamine, ∼22 × ∼14 × ∼8 à ; ATP, ∼19 × ∼9 × ∼8 à ; AMP-PNP, ∼19 × ∼9 × ∼6 à ; tetrameric avidin–MTS-biotin complex (PDB accession no. 1AVD) is ∼45-à wide × ∼58-à long.
	Figure 3. Similarly rapid decay of current in S549C CFTR channels (containing a single target Cys in the active catalytic site) upon ATP washout (w/o) or modification by MTS reagents. (A and B) S549C CFTR channels were activated by 3 mM ATP (black bars below records) and modified by 50 µM MTSET+ (A; red bars below record) or 5 and 50 µM MTSACE (B; green bars below record), and modification was reversed by DTT (A, 10 mM; B, 20 mM; black bars above record). Colored lines show single-exponential fits to current decay time courses on modification (τMTS) by MTSET+ (red) or by MTSACE (green), or on ATP removal (gray, τATPw/o) before modification, or on ATP removal after MTSACE modification (dotted green, τATPw/o(mod)); colored numbers give fit time constants; the time constants of Ca2+-dependent Cl− current decays in these patches were 0.3 s (A) and 0.2 s (B). (C) Average τATPw/o with corresponding average τMTS from the same patches (left: gray bar, w/o, 1.6 ± 0.2 s; red bar, ≥50 µM MTSET+, 1.4 ± 0.1 s; n = 6 measurements in five patches; right: gray bar, w/o, 3.5 ± 0.4 s; green bar, ≥50 µM MTSACE, 4.0 ± 1 s; n = 6 measurements in four patches); slower washout and modification time courses in the MTSACE experiments likely reflected slower superfusion influenced by patch geometry, but comparisons were always made within the same patch. (D) Averages of individual ratios of washout and modification time constants determined for each pair of measurements (from experiments of C; red open bar, τMTSET/τATPw/o, 0.9 ± 0.1; green open bar, τMTSACE/τATPw/o, 1.2 ± 0.3). (E) Average of washout time constant ratios, before and after MTSACE modification (green hatched bar, τATPw/o(mod)/τATPw/o, 0.9 ± 0.1; n = 5); absolute current amplitude of MTSACE-modified channels was 7–22 pA. Error bars represent mean ± SEM.
	Figure 4. S549C CFTR channels are readily modified by MTS reagents when closed. (A) Immediately after 60-s applications of 5 µM MTSET+ (red trace and bar), 100 µM MTSACE (green trace and bar), or 100 µM MTSES− (blue trace and bar) to closed S549C channels in the absence of ATP, brief exposures to 3 mM ATP (black bars below record) assessed residual channel activity; the time constant of Ca2+-dependent Cl− current decay in this patch was 0.2 s. Exposures to 10 mM DTT (black bars above record) fully restored ATP-activated current by releasing adducts after each modification. (B) Relative amplitude of residual ATP-dependent current (Iresidual %) of modified S549C channels. For modification while channels were closed (left, 0 ATP), residual ATP-activated current (peak current a few seconds after adding ATP minus baseline current just before ATP addition) of modified channels was compared with the average of peak ATP-activated currents of the same channels after full recovery from modification, and just before modification by MTSET+ (red bar, 6 ± 1%; n = 8 measurements in six patches), by MTSACE (green bar, 18 ± 2%; n = 5 measurements in four patches), or by MTSES− (blue bar, 17 ± 3%; n = 4 measurements in three patches). For modification while channels were opening and closing in ATP (right, 3 mM ATP), residual ATP-dependent current (measured as the difference before and after ATP removal) of modified channels was compared with ATP-activated current of the same channels immediately before modification by ≥50 µM MTSET+ (red bar, 4 ± 1%; n = 10 measurements in five patches) or by ≥50 µM MTSACE (green bar, 18 ± 6%; n = 4 measurements in four patches). Error bars represent mean ± SEM.
	Figure 5. Similarly rapid decay of current in S1347C CFTR channels (containing a single target Cys in the dead composite site) upon ATP washout (w/o) or modification by MTS reagents. (A and B) S1347C CFTR channels were activated by 3 mM ATP (black bars below records) and modified by 1 mM MTSET+ or MTSACE (A and B, red and green bars below records, respectively). Colored lines show single-exponential fits to current decay time courses on modification (τMTS) by MTSET+ (red) or by MTSACE (green), or on ATP removal (gray, τATPw/o) before modification, or on ATP removal after MTSET+ modification (dotted red, τATPw/o(mod)); colored numbers give time constants; the time constants of Ca2+-dependent Cl− current decays in these patches were 0.1 s (A) and 0.3 s (B). (C) Average τATPw/o (gray bars) with corresponding average τMTS from the same patches (left: gray bar, w/o, 0.8 ± 0.2 s; red bar, ≥50 µM MTSET+, 0.8 ± 0.2 s; n = 8 measurements in six patches; right: gray bar, w/o, 1.3 ± 0.1 s; green bar, ≥50 µM MTSACE, 0.9 ± 0.2 s; n = 9 measurements in seven patches). (D) Averages of individual ratios of washout and modification time constants determined for each pair of measurements (from experiments of C; red open bar, τMTSET/τATPw/o, 1.0 ± 0.1; green open bar, τMTSACE/τATPw/o, 0.8 ± 0.2). (E) Ratio of washout time constants before and after MTSET+ and MTSACE modification (τATPw/o(mod)/τATPw/o: red hatched bar, MTSET+, 1.5 ± 0.3, n = 8 measurements in six patches; green hatched bar, MTSACE, 1.0 ± 0.1; n = 8 measurements in seven patches); absolute current amplitudes were 5–64 pA for MTSET+-modified channels and 6–80 pA for MTSACE-modified channels. Error bars represent mean ± SEM.
	Figure 6. S1347C CFTR channels are readily modified by MTS reagents when closed. (A) Immediately after ∼60-s applications of 50 µM MTSET+ (red trace and bar), MTSACE (green trace and bar), or MTSES− (blue trace and bar) to closed S1347C channels in the absence of ATP, brief exposures to 3 mM ATP (black bars below record) assessed residual channel activity. Exposures to 20 mM DTT (black bars above record) restored ATP-activated current by releasing adducts after each modification; the asterisk above the record marks brief activation of Ca2+-dependent Cl− current to monitor solution exchange speed (time constant = 0.3 s for this patch). (B) Amplitude of residual ATP-dependent current (Iresidual %), relative to ATP-activated current before modification, for S1347C channels modified, while closed (left, 0 ATP), by MTSET+ (red bar, 33 ± 8%; n = 4 measurements in four patches), by MTSACE (green bar, 24 ± 6%; n = 3 measurements in three patches), or by MTSES− (blue bar, 16 ± 5%; n = 3 measurements in three patches), or while opening and closing (right, 3 mM ATP), by ≥50 µM MTSET+ (red bar, 42.4 ± 4.5%, n = 8 measurements in four patches) or by ≥50 µM MTSACE (green bar, 19.5 ± 2.0%, n = 9 measurements in four patches). Error bars represent mean ± SEM.
	Figure 7. Hydrolysis-impairing mutation, K1250R, of the conserved Walker A lysine in the active composite site similarly slows current decay after ATP washout and upon MTS modification of both S549C and S1347C channels. (A and B) ATP-activated (3 mM, black bars below records) currents of S549C-K1250R (A) and S1347C-K1250R (B) CFTR channels with single-exponential fits to current decline upon ATP removal (gray, τATP w/o) or modification (τMTS) by 50 µM MTSET+ (red) or MTSACE (green); 20 mM DTT (black bars above records) restored activation of currents by ATP; asterisks above the records mark brief activations of Ca2+-dependent Cl− currents to monitor speed of solution exchange (0.3 s in A and 0.2 s in B). (C) Average τATPw/o (gray bars) with corresponding average τMTS from the same patches (left, S549C-K1250R: gray bar, w/o, 17 ± 3.8 s; red bar, MTSET+, 20.9 ± 7.6 s; n = 3 measurements in three patches; right, S1347C-K1250R: gray bar, w/o, 15.4 ± 2.0 s; green bar, MTSACE, 18.6 ± 3.5 s; n = 9 and 7 measurements, respectively, in three patches). (D) Averages of individual ratios of washout and modification time constants determined for each pair of measurements (from experiments of C; red open bar, S549C-K1250R, τMTSET/τATPw/o, 1.2 ± 0.2; green open bar, S1347C-K1250R, τMTSACE/τATPw/o, 1.2 ± 0.1). Error bars represent mean ± SEM.
	Figure 8. Larger MTS reagents also readily modify S549C CFTR channels when they are closed. (A and B) ATP-activated current (3 mM, black bars below record) was strongly diminished after modification of closed S549C CFTR channels by ≤60-s exposures to larger MTS reagents, 20 µM MTS-glucose (A; orange bar), 5 µM MTS-rhodamine (A; magenta bar), 5 µM MTS-biotin (B; dark yellow bar), and MTS-biotin–avidin complex (B; 5 µM biotin plus 5 µM avidin, cyan bar), all in the absence of ATP; 10 mM DTT (black bars above records) released adducts after each modification; the time constants of Ca2+-dependent Cl− current decays in these patches were 0.5 s (A) and 0.2 s (B). (C) Amplitude of residual ATP-activated current (Iresidual %), relative to ATP-activated current before modification, for S549C channels modified, while closed (in 0 ATP), by MTS-biotin (dark yellow bar, 15 ± 3%, n = 7 measurements), by MTS-glucose (orange bar, 7 ± 1%, n = 3 measurements), by MTS-rhodamine (magenta bar, 5 ± 2%, n = 5 measurements), or by MTS-biotin–avidin complex (cyan bar, 90 ± 8%, n = 5 measurements). Error bars represent mean ± SEM.
	Figure 9. Larger MTS reagents relatively rapidly modify S1347C CFTR channels in the presence of ATP. (A and B) S1347C channels were activated by 3 mM ATP (black bars below records) and modified by 50 µM MTS-glucose (A and B; orange traces and bars), 50 µM MTSACE (A; green trace and bar), 50 µM MTS-biotin (A; dark yellow trace and bar), or 50 µM MTS-rhodamine (A; magenta trace and bar), but not by the MTS-biotin–avidin complex (B; 50 µM biotin plus 60 µM avidin, cyan trace and bar). Each modification was reversed by 20 mM DTT (A and B; black bars above record). Asterisks above the record in A mark brief activations of Ca2+-dependent Cl− currents to monitor speed of solution exchange (here, 0.3 s and 0.2 s); the gaps in A omit 30 and 450 s, and during the second gap the channels were rephosphorylated with PKA catalytic subunit. (C) Amplitude of residual ATP-activated current (Iresidual %), as a fraction of ATP-dependent current before MTS treatment, for S1347C channels modified, while opening and closing (in 3 mM ATP), by MTS-biotin (dark yellow bar, 16 ± 2%, n = 6 measurements in six patches), by MTS-glucose (orange bar, 14 ± 3%, n = 6 measurements in three patches), by MTS-rhodamine (magenta bar, 18 ± 6%, n = 6 measurements in five patches), and MTS-biotin–avidin complex (cyan bar, 119 ± 2%, n = 3 measurements in two patches). Error bars represent mean ± SEM.
	Figure 10. Similarly rapid decay of current in S605C CFTR channels (containing a mid-interface target Cys—in the NBD1 H loop—between the two composite sites) upon ATP washout (w/o) or modification by MTSET+. (A) S605C-(C832S-C1458S) CFTR channels were activated by 3 mM ATP (black bars below records) and modified by 1 mM MTSET+ (red bar). 10 mM DTT (black bars above record) kept the thiol reactive but could not remove the MTSET+ adduct. Colored lines show single-exponential fits to current decay time courses on modification by MTSET+ (red, τMTS), or on ATP removal (gray, τATPw/o) before modification, or on ATP removal after MTSET+ modification (dotted red, τATPw/o(mod)); colored numbers give time constants. (B) Amplitude of residual current (Iresidual %), relative to ATP-activated current before modification, for S605C channels modified in 3 mM ATP by 1 mM MTSET+ (red bar, 21 ± 4%, n = 4 measurements in four patches). (C) Average τATPw/o (gray bar, w/o, 0.9 ± 0.2 s; n = 4 measurements in four patches) with corresponding average τMTS (red bar, MTSET+, 1.1 ± 0.1 s) from the same patches. (D) Average of individual ratios of washout and modification time constants determined for each pair of measurements (from experiments of C; red open bar, τMTSET/τATPw/o, 1.5 ± 0.3). (E) Ratio of washout time constants before and after MTSET+ modification (τATPw/o(mod)/τATPw/o: red hatched bar, 0.9 ± 0.2, n = 4 measurements in four patches); absolute current amplitudes were 13–32 pA for MTSET+-modified channels. Error bars represent mean ± SEM.
	Figure 11. Rapid decay of current in A1374C CFTR channels (containing a mid-interface target Cys—in the NBD2 D loop—between the two composite sites) upon ATP washout (w/o) or modification by MTSET+. (A and B) A1374C-(C832S-C1458S) CFTR channels were modified by 1 mM MTSET+ (red trace bar) either while closed in the absence of ATP (A), as assessed by subsequent diminished ATP-activated current (3 mM, black bars below records), or in the presence of ATP (B). 10 mM DTT (black bars above record) removed the MTSET+ adduct after each modification. (B) Colored lines show single-exponential fits to current decay time courses on modification by MTSET+ (red, τMTS), or on ATP removal (gray, τATPw/o); colored numbers give time constants. (C) Amplitude of residual current (Iresidual %), relative to ATP-activated current before modification, for A1374C channels modified, while closed (left, 0 ATP), by 5 µM–1 mM MTSET+ (red bar, 9 ± 2%; n = 8 measurements in six patches), or while opening and closing (right, 3 mM ATP), by 10 µM–1 mM MTSET+ (red bar, 17 ± 6%, n = 3 measurements in two patches). (D) Average τATPw/o (gray bar, w/o, 1.2 ± 0.6 s; n = 4 measurements in three patches) with corresponding average τMTS (red bar, MTSET+, 2.5 ± 0.9 s) from the same patches. Error bars represent mean ± SEM.

Aleksandrov, The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover. 2002, Pubmed

Aleksandrov, The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover. 2002, Pubmed
Aleksandrov, Mg2+ -dependent ATP occlusion at the first nucleotide-binding domain (NBD1) of CFTR does not require the second (NBD2). 2008, Pubmed
Aller, Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. 2009, Pubmed
Bai, Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation. 2010, Pubmed
Basso, Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating. 2003, Pubmed , Xenbase
Baukrowitz, Coupling of CFTR Cl- channel gating to an ATP hydrolysis cycle. 1994, Pubmed
Boël, The ABC-F protein EttA gates ribosome entry into the translation elongation cycle. 2014, Pubmed
Cai, Voltage-dependent gating of the cystic fibrosis transmembrane conductance regulator Cl- channel. 2003, Pubmed
Carson, The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. 1995, Pubmed
Chan, Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain. 2000, Pubmed , Xenbase
Chen, A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. 2003, Pubmed
Chen, CLC-0 and CFTR: chloride channels evolved from transporters. 2008, Pubmed
Cotten, Covalent modification of the regulatory domain irreversibly stimulates cystic fibrosis transmembrane conductance regulator. 1997, Pubmed
Cotten, Covalent modification of the nucleotide binding domains of cystic fibrosis transmembrane conductance regulator. 1998, Pubmed
Csanády, Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains. 2000, Pubmed , Xenbase
Csanády, Strict coupling between CFTR's catalytic cycle and gating of its Cl- ion pore revealed by distributions of open channel burst durations. 2010, Pubmed , Xenbase
Csanády, Conformational changes in the catalytically inactive nucleotide-binding site of CFTR. 2013, Pubmed , Xenbase
Csanády, Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle. 2006, Pubmed , Xenbase
Cui, The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating. 2006, Pubmed
Davidson, Structure, function, and evolution of bacterial ATP-binding cassette systems. 2008, Pubmed
Dawson, Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. 2007, Pubmed
Dawson, Structure of a bacterial multidrug ABC transporter. 2006, Pubmed
Fetsch, Vanadate-catalyzed photocleavage of the signature motif of an ATP-binding cassette (ABC) transporter. 2002, Pubmed
Gadsby, The ABC protein turned chloride channel whose failure causes cystic fibrosis. 2006, Pubmed
Gao, Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. 2000, Pubmed
Gunderson, Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating. 1994, Pubmed
Gunderson, Conformational states of CFTR associated with channel gating: the role ATP binding and hydrolysis. 1995, Pubmed
Hohl, Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation. 2012, Pubmed
Hohl, Structural basis for allosteric cross-talk between the asymmetric nucleotide binding sites of a heterodimeric ABC exporter. 2014, Pubmed
Hopfner, Rad50/SMC proteins and ABC transporters: unifying concepts from high-resolution structures. 2003, Pubmed
Hopfner, Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily. 2000, Pubmed
Hou, Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1. 2000, Pubmed
Hung, Crystal structure of the ATP-binding subunit of an ABC transporter. 1998, Pubmed
Janas, The ATP hydrolysis cycle of the nucleotide-binding domain of the mitochondrial ATP-binding cassette transporter Mdl1p. 2003, Pubmed
Jin, Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans. 2012, Pubmed
Karlin, Substituted-cysteine accessibility method. 1998, Pubmed
Khare, Alternating access in maltose transporter mediated by rigid-body rotations. 2009, Pubmed
Kim, Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter. 2015, Pubmed
Kodan, Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog. 2014, Pubmed
Kuruma, Bimodal control of a Ca(2+)-activated Cl(-) channel by different Ca(2+) signals. 2000, Pubmed , Xenbase
Lamers, The alternating ATPase domains of MutS control DNA mismatch repair. 2003, Pubmed
Lee, Structural basis for heavy metal detoxification by an Atm1-type ABC exporter. 2014, Pubmed
Lerner-Marmarosh, Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins. 1999, Pubmed
Lewis, Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. 2004, Pubmed
Li, Allosteric transitions of the maltose transporter studied by an elastic network model. 2014, Pubmed
Loo, Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites. 2000, Pubmed
Lubelski, LmrCD is a major multidrug resistance transporter in Lactococcus lactis. 2006, Pubmed
Matsuo, ATP binding properties of the nucleotide-binding folds of SUR1. 1999, Pubmed
Mense, In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. 2006, Pubmed , Xenbase
Moody, Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. 2002, Pubmed
Moradi, Mechanistic picture for conformational transition of a membrane transporter at atomic resolution. 2013, Pubmed
Nagata, Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1. 2000, Pubmed
Oldham, Crystal structure of the maltose transporter in a pretranslocation intermediate state. 2011, Pubmed
Oldham, Snapshots of the maltose transporter during ATP hydrolysis. 2011, Pubmed
Powe, Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains. 2002, Pubmed
Procko, Distinct structural and functional properties of the ATPase sites in an asymmetric ABC transporter. 2006, Pubmed
Puljung, New structural insights into the gating movements of CFTR. 2015, Pubmed
Ramjeesingh, Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator). 1999, Pubmed
Rees, ABC transporters: the power to change. 2009, Pubmed
Senior, The catalytic cycle of P-glycoprotein. 1995, Pubmed
Shintre, Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states. 2013, Pubmed
Siarheyeva, Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis. 2010, Pubmed
Smith, ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. 2002, Pubmed
Srinivasan, Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1. 2014, Pubmed
Szabó, Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator. Different patterns in the two nucleotide binding domains. 1999, Pubmed
Szollosi, Involvement of F1296 and N1303 of CFTR in induced-fit conformational change in response to ATP binding at NBD2. 2010, Pubmed , Xenbase
Szollosi, Mutant cycles at CFTR's non-canonical ATP-binding site support little interface separation during gating. 2011, Pubmed , Xenbase
Tombline, The occluded nucleotide conformation of p-glycoprotein. 2005, Pubmed
Tsai, State-dependent modulation of CFTR gating by pyrophosphate. 2009, Pubmed
Tsai, Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. 2010, Pubmed
Urbatsch, Cysteines 431 and 1074 are responsible for inhibitory disulfide cross-linking between the two nucleotide-binding sites in human P-glycoprotein. 2001, Pubmed
Urbatsch, Both P-glycoprotein nucleotide-binding sites are catalytically active. 1995, Pubmed
Verdon, Formation of the productive ATP-Mg2+-bound dimer of GlcV, an ABC-ATPase from Sulfolobus solfataricus. 2003, Pubmed
Vergani, On the mechanism of MgATP-dependent gating of CFTR Cl- channels. 2003, Pubmed , Xenbase
Vergani, CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. 2005, Pubmed
Ward, Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain. 2013, Pubmed
Ward, Flexibility in the ABC transporter MsbA: Alternating access with a twist. 2007, Pubmed
Zaitseva, Functional characterization and ATP-induced dimerization of the isolated ABC-domain of the haemolysin B transporter. 2005, Pubmed
Zutz, Asymmetric ATP hydrolysis cycle of the heterodimeric multidrug ABC transport complex TmrAB from Thermus thermophilus. 2011, Pubmed